Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07409350 · ClinicalTrials.gov registry record · NA
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 398
- Enrollment target
NCT07409350: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT07409350 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 398 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07409350, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
Study Summary
This study includes finalization of the LINKED social network intervention to improve PrEP and MOUD uptake among people who inject drugs (PWID) in collaboration with an Expert Advisory Board and staff (N=16) at The Sidewalk Project (TSP), followed by a Hybrid Type II cluster randomized trial of the LINKED intervention (versus an equal-attention control) among N=372 people who inject drugs, with 6- and 12-month follow-up assessment of PrEP and MOUD uptake. The investigators will also evaluate implementation outcomes to inform future sustainable implementation of LINKED in harm reduction organizations.
Primary Outcome
Measured via filled PrEP prescription.
Interventions
- BEHAVIORAL Group Intervention
- BEHAVIORAL LINKED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2027-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
What is known before NCT07409350 opens enrollment
NCT07409350 is an interventional study that assigns participants to a tested intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Group Intervention is the first listed.
NCT07409350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07409350 about?
NCT07409350 is a clinical study titled "A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs". This study includes finalization of the LINKED social network intervention to improve PrEP and MOUD uptake among people who inject drugs (PWID) in collaboration with an Expert Advisory Board and staff (N=16) at The Sidewalk Project (TSP), followed by a Hybrid Type II cluster randomized trial of the ...
What is the current status of trial NCT07409350?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 398 participants. The study started on 2027-01. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07409350?
The interventions under investigation include: Group Intervention (BEHAVIORAL), LINKED (BEHAVIORAL).
Who is sponsoring clinical trial NCT07409350?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07409350's enrollment target sits among peer trials
398 267th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia